Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Peter O Simon"'
Autor:
William G. Hawkins, Robert H. Mach, Richard S. Hotchkiss, Peter Goedegebuure, John R. Hornick, Jonathan E. McDunn, Katherine Chang, Dong Zhou, Suwanna Vangveravong, Chenbo Zeng, Jinbin Xu, Hiroyuki Kashiwagi, Peter O. Simon, Dirk Spitzer
PDF file - 83K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f5195712a9d3dfcf992e528acaba0a5
https://doi.org/10.1158/0008-5472.22390836.v1
https://doi.org/10.1158/0008-5472.22390836.v1
Autor:
William G. Hawkins, Robert H. Mach, Richard S. Hotchkiss, Peter Goedegebuure, John R. Hornick, Jonathan E. McDunn, Katherine Chang, Dong Zhou, Suwanna Vangveravong, Chenbo Zeng, Jinbin Xu, Hiroyuki Kashiwagi, Peter O. Simon, Dirk Spitzer
One major challenge in the development of cancer therapeutics is the selective delivery of the drugs to their cellular targets. In the case of pancreatic cancer, the σ-2 receptor is a unique target that triggers apoptosis upon activation. We have pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37e6334d1de2292e5b6a98c93602befc
https://doi.org/10.1158/0008-5472.c.6503079.v1
https://doi.org/10.1158/0008-5472.c.6503079.v1
Autor:
William A Gray, Koen Keirse, Yoshimitsu Soga, Andrew Benko, Anvar Babaev, Yoshiaki Yokoi, Henrik Schroeder, Jeffery T Prem, Andrew Holden, Jeffrey Popma, Michael R Jaff, Juan Diaz-Cartelle, Stefan Müller-Hülsbeck, Thomas Albrecht, Kenji Ando, Michael J Bacharach, William Bachinsky, Danielle Bajakian, Robert Beasley, James Benenati, Mark Burket, Joseph Cardenas, Tony Das, Randall De Martino, Hannes Deutschmann, Daniel Dulas, Robert Feldman, Mark Fugate, Lawrence Garcia, Jaafer Golzar, Rao Gutta, Patrick Hall, Stewart Hawkins, Steve Henao, Benjamin Herdrich, Keisuke Hirano, Safwan Jaalouk, Sean Janzer, Daizo Kawasaki, Yazan Khatib, Kimihiko Kichikawa, Ethan Korngold, Christian Loewe, Louis Lopez, Henry Lui, Toshiaki Mano, Robert Mendes, Akira Miyamoto, Masato Nakamura, David O'Connor, Takao Ohki, James Park, Richard Powell, Antonis Pratsos, Jeffery Prem, Vikram Rao, John Rashid, Robert Rhee, Jason Ricci, Dierk Scheinert, Herman Schroë, Peter O Simon, Gagan Singh, Kongteng Tan, Paul Tolerico, Thodur Vasudevan, Frank Vermassen, Martin Werner, Bret Wiechmann, Hiroyoshi Yokoi, Thomas Zeller
Publikováno v:
The Lancet. 392:1541-1551
Summary Background The clinical effect of a drug-eluting stent in the femoropopliteal segment has not been investigated in a randomised trial with a contemporary comparator. The IMPERIAL study sought to compare the safety and efficacy of the polymer-
Autor:
Peter O. Simon, Andrew Poole, Quanjun Cui, Laura H. Schapiro, Wendy M. Novicoff, Matthew C. Kinney
Publikováno v:
American Journal of Medical Quality. 28:335-338
The objective of this study was to determine whether the use of a knee immobilizer brace reduces patient falls associated with the recent use of femoral nerve blocks for pain control after total knee arthroplasty (TKA). The authors conducted a retros
Autor:
Albert C. Lockhart, Steven Sorscher, Andrea Wang-Gillam, Benjamin R. Tan, Rama Suresh, Jonathan B. Mitchem, Peter S. Goedegebuure, Joel Picus, Stacey Plambeck-Suess, John R. Hornick, Peter O. Simon, W. Hawkins
Publikováno v:
Investigational New Drugs. 31:707-713
Purpose This phase I study was conducted to determine the safety profile and maximum tolerated dose (MTD) of IMP321, a soluble lymphocyte activation gene-3 (LAG-3) Ig fusion protein and MHC Class II agonist, combined with gemcitabine in patients with
Autor:
Wael E. Saad, Peter O. Simon
Publikováno v:
Ultrasound Clinics. 7:283-297
Autor:
Suwanna Vangveravong, Jinbin Xu, Peter O. Simon, Hiroyuki Kashiwagi, William G. Hawkins, Dirk Spitzer, Jonathan E. McDunn, Chenbo Zeng, Katherine Chang, Dong Zhou, John R. Hornick, Richard S. Hotchkiss, Robert H. Mach, Peter S. Goedegebuure
Publikováno v:
Cancer Research. 72:201-209
One major challenge in the development of cancer therapeutics is the selective delivery of the drugs to their cellular targets. In the case of pancreatic cancer, the σ-2 receptor is a unique target that triggers apoptosis upon activation. We have pr
Autor:
Riad R. Azar, Morgan Younkin, Michael Chamberlin, Steven M. Strasberg, Steven A. Edmundowicz, David C. Linehan, Fabian M. Johnston, John R. Hornick, William G. Hawkins, Peter O. Simon, Jonathan B. Mitchem
Publikováno v:
Surgery. 150:169-176
Background Although benign ampullary tumors are removed endoscopically, due to their potential to progress to malignant disease, the favored treatment for adenocarcinoma is pancreaticoduodenectomy. We reviewed our institution's experience in order to
Publikováno v:
Journal of Vascular and Interventional Radiology. 25:1306-1308
determine a systemic allergic reaction, as reported in the present patient. The present patient had an early reaction with generalized pruritus, rash, and leg edema, suggesting an immediate systemic reaction to nickel exposure. Although a transitory
Autor:
Steven M. Strasberg, William G. Hawkins, Fabian M. Johnston, David C. Linehan, Nicholas A. Hamilton, Antonino Cavataio, Kathryn Trinkaus, Peter O. Simon, M.B. Majella Doyle, Matthew R. Porembka, Brent D. Mathews
Publikováno v:
HPB. 11:25-31
BackgroundPancreatic occlusion failure (POF) after distal pancreatectomy remains a common source of morbidity. Here, we review our experience with distal pancreatectomy and attempt to identify factors which influence POF rates.Patients and MethodsOne